• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Manifest Learning Academy
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Science & Tech

Maharashtra’s mass drug administration against Lymphatic Filariasis

July 12, 2021
in Science & Tech
Reading Time: 3 mins read
0
Maharashtra’s mass drug administration against Lymphatic Filariasis
114
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook
image_pdfMake PDF

In news 

The state government of Maharashtra has flagged off its mass drug administration drive for the elimination of lymphatic filariasis and become the first State in the country to resume giving rounds of the drug after the second wave of COVID-19. 

About Mass Drug Administration(MDA) drive 

  • It will be conducted in six districts Bhandara, Chandrapur, Gadchiroli, Gondia, Yavatmal and Nanded till July 15. 
  • Of the six districts, Gadchiroli, Chandrapur and Bhandara will undertake the triple drug therapy. 
  • Maharashtra has 18 filariasis endemic districts.
  • MDA is one of the two pillars of the National Programme for Elimination of Lymphatic Filariasis, under which anti-filaria drugs are administered to the eligible population once a year.
  • Everyone except pregnant women, children below five years and seriously ill people will be administered the drugs in the presence of health workers.
  • Triple-drug therapy is a new drug combination approved by the WHO, has been proven to be more effective and helpful in reducing the number of MDA rounds needed to eliminate filariasis.

What are the drugs used in the drive?

A combination of two drugs, diethylcarbamazine (DEC) and albendazole, or three Ivermectin, DEC, and Albendazole will be administered during the drive.

About Lymphatic Filariasis 

    • Known as elephantiasis, filariasis is the second most disabling disease after mental health according to WHO and is transmitted by infected mosquitoes. 
    • It is a painful and profoundly disfiguring disease. 
    • It is caused by infection with parasites classified as nematodes (roundworms) of the family Filarioidea that are transmitted through the bites of infected mosquitos. 
  •  90% of cases are accounted for by WuchereriaBancrofti worms.
  • The rest of the remaining cases are caused by BrugiaMalayi and BrugiaTimori.
  • Mosquito-transmitted larvae are deposited on the skin from where they can enter the body. 
  • The larvae then migrate to the lymphatic vessels where they develop into adult worms, thus continuing a cycle of transmission.
  • It is a neglected tropical disease.

  • Usually acquired in childhood, the infection damages the lymphatic system and if left untreated, causes enlargement of body parts.
  • Most cases are symptomless. Rarely, long-term damage to the lymph system causes swelling in the legs, arms and genitalia. 
  • It also increases the risk of frequent bacterial infections that harden and thicken the skin (elephantiasis).

Case in India

  • About 5 crore people in India were carrying the worm as of the early 2010s, which is 40% of all the cases in the world.
  • Indian government introduced the Accelerated Lymph Filariasis Elimination Plan (APELF) in 2018.
  • In October 2019 the Union health minister said that India’s current plan is on schedule to eradicate filariasis by 2021.

Global Programme to Eliminate Lymphatic Filariasis (GPELF)

  • In 2000, WHO established the GPELF to stop transmission of infection with mass drug administration (MDA) and to alleviate suffering among people affected by the disease through morbidity manage-ment and disability prevention (MMDP)
  • GPELF aims to reduce the prevalence of infection below target thresholds and to alleviate the suffering of people affected by lymphoedema and hydrocele, the chronic manifestations of the disease
  • The target set by GPELF in 2000 to eliminate LF as a public health problem globally by 2020 will not be achieved by then. 
  • Despite setbacks due to COVID-19, WHO will accelerate work to achieve this target by 2030
image_pdfMake PDF
Source: The Hindu
Tags: News PaperPrelims

Related Posts

What is the Large Hadron Collider?

What is the Large Hadron Collider?

July 5, 2022
‘IDIOT’ syndrome

‘IDIOT’ syndrome

July 4, 2022
Fujian-new high tech aircraft carrier of China

Fujian-new high tech aircraft carrier of China

July 4, 2022
PSLV Orbital Experimental Module (POEM)

PSLV Orbital Experimental Module (POEM)

July 2, 2022
GEMCOVAC-19, India’s first mRNA Covid-19 vaccine

GEMCOVAC-19, India’s first mRNA Covid-19 vaccine

July 2, 2022
CAPSTONE, NASA’s new satellite

CAPSTONE, NASA’s new satellite

July 1, 2022
Microbialcreat composite

Microbialcreat composite

June 30, 2022
Psyche mission

Psyche mission

June 29, 2022
VL-SRSAM missile system

VL-SRSAM missile system

June 28, 2022
Wind Energy potential in India

Wind Energy potential in India

June 27, 2022
Please login to join discussion

Our Offline Classroom Student

PRELIMS 2021 POLITY QUESTIONS ANALYSED

https://youtu.be/5q8hBcRGhAs

PRELIMS 2021 HISTORY QUESTIONS ANALYSED

https://youtu.be/v0SIZ7SUybg

CONGRATULATIONS TO 2021 TOPPERS !!!

Rank 171 Kumar Shivashish
Rank 250 Sahithya
Rank 263 Sumit Kumar Thakur
Rank 311 Deepak Ramachandra Shet
Rank 455 Ravinandan B M

July 2022
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jun    

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tags

AIR BBC Business Standard CNN Deccan Herald DownToEarth Down to Earth DTE Economic Times ET GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express India today Indiatoday Kurukshetra LiveMint Mains News Newspaper News Paper PIB PIB & The Hindu pre Prelims PRS India RSTV Science Reporter Survey The Hindu The Hindustan Times The India Express The Indian Express The New Indian Express Times of India TOI TOPPERS UNDP website Wikipedia Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tag

AIR BBC Business Standard CNN Deccan Herald DownToEarth Down to Earth DTE Economic Times ET GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express India today Indiatoday Kurukshetra LiveMint Mains News Newspaper News Paper PIB PIB & The Hindu pre Prelims PRS India RSTV Science Reporter Survey The Hindu The Hindustan Times The India Express The Indian Express The New Indian Express Times of India TOI TOPPERS UNDP website Wikipedia Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In